Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) EBT Margin: 2020-2025

Historic EBT Margin for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -95.06%.

  • Biofrontera's EBT Margin fell 3219.00% to -95.06% in Q3 2025 from the same period last year, while for Sep 2025 it was -47.22%, marking a year-over-year decrease of 1097.00%. This contributed to the annual value of -47.53% for FY2024, which is 1152.00% up from last year.
  • Per Biofrontera's latest filing, its EBT Margin stood at -95.06% for Q3 2025, which was down 61.87% from -58.73% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's EBT Margin registered a high of 57.34% during Q1 2022, and its lowest value of -369.31% during Q3 2021.
  • In the last 3 years, Biofrontera's EBT Margin had a median value of -62.87% in 2024 and averaged -63.93%.
  • Per our database at Business Quant, Biofrontera's EBT Margin slumped by 27,940bps in 2021 and then spiked by 30,996bps in 2022.
  • Biofrontera's EBT Margin (Quarterly) stood at -158.16% in 2021, then surged by 13,071bps to -27.44% in 2022, then surged by 6,066bps to 33.22% in 2023, then slumped by 4,436bps to -11.14% in 2024, then slumped by 3,219bps to -95.06% in 2025.
  • Its last three reported values are -95.06% in Q3 2025, -58.73% for Q2 2025, and -48.95% during Q1 2025.